tirzepatide and cancer 💊 Weight-loss drug shows cancer-fighting potential Researchers at the University of Michigan discovered that (Mounjaro, Zepbound), already FDA-approved for diabetes obesity, also shrinks breast tumors in obese mice. When Can you take Mounjaro if

This ruling puts immense pressure on medspa owners to navigate a complex and shifting regulatory landscapeall while trying to serve their patients

E.HamadaH

Use the slider to select either the IC3 or IC5 port and then charge your battery with up to 100W power

Willow GLP-1 Medication Options FAQ Spotlight: Is a specific medication or brand guaranteed on Willow

FDA submission is likely coming in 2026/2027 if the remaining readouts hold up Some other noteworthy drugs in the pipeline: Tirzepatide: The base drug is already approved for diabetes and obesity, but Lilly keeps expanding its label Kisunla (donanemab) for Alzheimer's Eloralintide: amylin receptor agonist heading to phase 3, at ADA it showed 20% weight loss on the amylin pathway alone MORF-057: bit of a wild card, after the $3.2 billion acquisition of Morphic